Posttransplantation lymphoproliferative disorder of the head and neck: Imaging features in seven adults

Radiology

Volumn 216, Issue 2, 2000, Pages 363-369

  Loevner, Laurie A ^a   Karpati, Ronit L ^a   Kumar, Priya ^a   Yousem, David M ^a   Hsu, Wendy ^a   Montone, Kathleen T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Head and neck neoplasms; Head and neck neoplasms, CT; Head and neck neoplasms, MR; Lymphatic system neoplasms; Transplantation

Indexed keywords

ADULT; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPHATIC SYSTEM; LYMPHATIC SYSTEM DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; WALDEYER RING;

EID: 0033880822     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.216.2.r00au24363     Document Type: Article

References (32)

1. Starzl TE. In discussion of: Murray JE, Wilson RE, Tilney NL, et al. Five years experience with renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968; 168:416.
2. Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994; 97: 14-24.
3. Swerdlow SH. Classification of the post-transplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 1997; 14:2-7.
4. Montone KT, Litzky LA, Wurster A, et al. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Surgery 1996; 119:544-551.
5. Benkerrou M, Durandy A, Fischer A. Therapy for transplant-related lymphoproliferative disease. Hematol Oncol Clin North Am 1993; 7:467-475.
6. Basgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am 1995; 9:901-923.
7. Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating EBV-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994; 3:972-984.
8. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995; 14:214-221.
9. Reynders CS, Whitman GJ, Chew FS. Posttransplant lymphoproliferative disorder of the lung. AJR Am J Roentgenol 1995; 14:214-221.
10. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173-192.
11. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disease. Blood 1995; 85:552-565.
12. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasia and lymphoma in renal transplant recipients. Cancer Res 1981; 41:4262-4279.
13. Hanson MN, Morrison VA, Peterson BA, et al. Post-transplant T-cell lymphoproliferative disorder: an aggressive, late complication of solid organ transplantation. Blood 1996; 88:3626-3633.
14. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982; 306:913-918.
15. Boulter A, Johnson NW, Birnhaum W, Teo CG. Epstein-Barr virus associated lesions of the head and neck. Oral Dis 1996; 2:117-124.
16. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993; 99:265-276.
17. Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 1996; 9:621-630.
18. Montone KT, Hodinka RL, Tomaszewski JE. Identification of Epstein-Barr virus lytic and latent RNA transcripts in post-transplant lymphoproliferative disorder, Int J Surg Pathol 1995; 3:119-130.
19. Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovase Surg 1996; 8:139-148.
20. Lucas KG, Pollok KE, Emanuel DJ. Post-transplant EBV induced lymphoproliferative disorders. Leuk Lymphoma 1997; 25: 1-8.
21. Pickhardt PJ, Siegel MJ, Anderson DC, Hayashi R, DeBaun MR. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients. AJR Am J Roentgenol 1998; 171:375-382.
22. Rappaport DC, Chamberlain DW, Shepherd FA, Hutcheon MA. Lymphoproliferative disorders after lung transplantation: imaging features. Radiology 1998; 206:519-524.
23. Dodd GD, Ledesma-Medina J, Baron RL, Fuhrman CR. Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 1992; 184:65-69.
24. Carignan S, Staples CA, Muller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology 1995; 197:53-58.
25. Tubman DE, Frick MP, Hanto DW. Lymphoma after organ transplantation: radiologic manifestations in the central nervous system, thorax, and abdomen. Radiology 1983; 149:625-631.
26. Strouse PJ, Platt JF, Francis IR, Bree RL. Tumorous intrahepatic lymphoproliferative disorder in transplanted livers. AJR Am J Roentgenol 1996; 167:1159-1162.
27. Donnelly LF, Frush DP, Marshall KW, White KS. Lymphoproliferative disorders: CT findings in immunocompromised children. AJR Am J Roentgenol 1998; 171: 725-731.
28. Miller WT Jr, Siegel SG, Montone KT. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 1997; 38:569-585.
29. Sculerati N, Arriaga M. Otolaryngologic management of posttransplant lymphoproliferative disease in children. Ann Otol Rhinol Laryngol 1990; 99:445-450.
30. Deschler DG, Osorio R, Ascher NL, Lee KC. Posttransplant lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. Arch Otolaryngol Head Neck Surg 1995; 121:1037-1041.
31. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1:584-587.
32. Murray KA, Chor PJ, Turner JF Jr. Intrathoracic lymphoproliferative disorders and lymphoma. Curr Probl Diagn Radiol 1996; 25:78-106.